- American City Business Journals•16 hours ago
The World Health Organization said Monday that the world’s first malaria vaccine, which features a key component made by Lexington biotech Agenus, will be available in parts of Africa beginning next year. The WHO’s African regional office said that Ghana, Kenya and Malawi would participate in a pilot program for the injectable vaccine, which was developed by U.K. drug giant GlaxoSmithKline (GSK) with funding from the Bill & Melinda Gates Foundation. The vaccine contains a so-called adjuvant made by Agenus (AGEN), which is designed to boost the body’s immune response.
- Motley Fool•3 days ago
High dividend yields for CenturyLink, GlaxoSmithKline, and Teva look great, but there's more to the story for these stocks.
- Forbes•3 days ago
Barclays CEO Jes Staley's efforts to hunt down a whistleblower show that he was either incompetent or unfit to head the bank.
GSK.BA : Summary for GLAXOSMITHKLINE CEDEAR EACH REP - Yahoo Finance
GLAXOSMITHKLINE CEDEAR EACH REP (GSK.BA)
Buenos Aires - Buenos Aires Delayed Price. Currency in ARS
Add to watchlist
|Day's Range||160.05 - 160.05|
|52 Week Range||150.45 - 160.05|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|